Oct 3 (Reuters) - Dri Healthcare Trust DHT_u.TO :
* DRI HEALTHCARE TRUST ANNOUNCES ACQUISITION OF A ROYALTY
INTEREST
IN THE WORLDWIDE SALES OF OMIDRIA® FOR INTRACAMERAL USE DURING
CATARACT SURGERY OR INTRAOCULAR LENS REPLACEMENT
* DRI HEALTHCARE TRUST - PROPOSED DEAL FOR A PURCHASE PRICE
OF
US$125 MILLION
* DRI HEALTHCARE TRUST - ROYALTIES WILL BE RECEIVED BY DRI
MONTHLY
AND WILL BE SUBJECT TO ANNUAL CAPS
Source text for Eikon: ID:nCNWKr8Yxa
Further company coverage: DHT_u.TO
((Reuters.Briefs@thomsonreuters.com;))